CA2373312C - Mutant 1,3-propanediol dehydrogenase - Google Patents

Mutant 1,3-propanediol dehydrogenase Download PDF

Info

Publication number
CA2373312C
CA2373312C CA2373312A CA2373312A CA2373312C CA 2373312 C CA2373312 C CA 2373312C CA 2373312 A CA2373312 A CA 2373312A CA 2373312 A CA2373312 A CA 2373312A CA 2373312 C CA2373312 C CA 2373312C
Authority
CA
Canada
Prior art keywords
propanediol
mutant
propanediol dehydrogenase
dehydrogenase
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2373312A
Other languages
French (fr)
Other versions
CA2373312A1 (en
Inventor
Donald E. Trimbur
Gregory M. Whited
Olga V. Selifonova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International Inc filed Critical Genencor International Inc
Publication of CA2373312A1 publication Critical patent/CA2373312A1/en
Application granted granted Critical
Publication of CA2373312C publication Critical patent/CA2373312C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to mutant 1,3-propanediol dehydrogenase and a novel microorganism that is capable of growing in concentrations of at least 105 g/l 1,3-propanediol, levels normally toxic to wild-type microorganisms. The present invention also provides expression vectors and host cells comprising the mutant 1,3-propanediol dehydrogenase as well as methods for producing 1,3-propanediol comprising the use of cells comprising the mutant 1,3-propanediol dehydrogenase.

Description

MUTANT 1,3-PROPANEDIOL DEHYDROGENASE

FIELD OF THE INVENTION
The present invention relates to mutant 1,3-propanediol dehydrogenase having an altered Km for 1,3-propanediol. The present invention provides the nucleic acid and amino acid sequence of the mutant form of 1,3-propanediol dehydrogenase. The present invention also provides expression vectors and host cells comprising mutant 1,3-propanediol dehydrogenase.
BACKGROUND OF THE INVENTION
1,3-Propanediol is a monomer having potential utility in the production of polyester fibers and the manufacture of polyurethanes and cyclic compounds. The production of 1,3-propanediol has been disclosed in United States patent 5,686,276 issued November 11, 1997 and WO 98/21341. One representative pathway for the production of 1,3-propanediol from glucose can be accomplished by the following series of steps. Glucose is converted in a series of steps by enzymes of the glycolytic pathway to dihydroxyacetone phosphate (DHAP) and 3-phosphoglyceraldehyde (3-PG). Glycerol is then formed by either hydrolysis of DHAP to dihydroxyacetone (DHA) followed by reduction, or reduction of DHAP
to glycerol 3-phosphate (G3P) followed by hydrolysis. The hydrolysis step can be catalyzed by any number of cellular phosphatases which are known to be specific or non-specific with respect to their substrates or the activity can be introduced into the host by recombination. The reduction step can be catalyzed by a NAD+ (or NADP+) linked host enzyme or the activity can be introduced into the host by recombination. It is notable that the dha regulon contains a glycerol dehydrogenase (E.C. 1.1.1.6) which catalyzes the reversible reaction of Equation 3.

Glycerol 3-HP + H20 (Equation 1) 3-HP + NADH + H+ 1,3-Propanediol + NAD+ (Equation 2) Glycerol + NAD DHA + NADH + H+ (Equation 3) Glycerol is converted to 1,3-propanediol via the intermediate 3-hydroxypropionaldehye (3-HP) as has been described in detail above. The intermediate 3-HP is produced from glycerol (Equation 1) by a dehydratase enzyme which can be encoded by the host or can introduced into the host by recombination. This dehydratase can be glycerol dehydratase (E.C. 4.2.1.30), diol dehydratase (E.C. 4.2.1.28), or any other enzyme able to catalyze this transformation. Glycerol dehydratase is encoded by the dha regulon. 1,3-Propanediol is produced from 3-HP (Equation 2) by a NAD+- (or NADP+) linked host enzyme or the activity can introduced into the host by recombination. This final reaction in the production of 1,3-propanediol can be catalyzed by 1,3-propanediol dehydrogenase (E.C.
1.1.1.202) or other alcohol dehydrogenases.
In Klebsiella pneumoniae and Citrobacter freundii, the genes encoding the functionally linked activities of glycerol dehydratase (dhaB), 1,3-propanediol oxidoreductase (dhaT), glycerol dehydrogenase (dhaD), and dihydroxyacetone kinase (dhaK) are encompassed by the dha regulon. The dha regulons from Citrobacter and Klebsiella have been expressed in Escherichia coli and have been shown to convert glycerol to 1,3-propanediol.
Nucleic acid and amino acid sequences for a 1,3-propanediol dehydrogenase that have been disclosed in the art, including Klebsiella pneumoniae GenBank accession #
U30903 (Williard, 1994, "Investigation of the Klebsiella pneumoniae 1,3-propanediol pathway: Characterization and expression of glycerol dehydratase and 1,3-propanediol oxidoreductase" Thesis Chemical Engineering, University of Wisconsin-Madison);
Citrobacter freundii GenBank accession # U09771 (Daniel, R. et al., 1995, Purification of 1,3-propanediol dehydrogenase from Citrobacter freundii: cloning, sequencing, and overexpression of the corresponding gene in Escherichia coli. J. Bacteriol.
177:2151-2156);
and Clostridium pasteurianum GenBank accession # AF006034 (Luers,F. et al., 1997, Glycerol conversion to 1,3-propanediol by Clostridium pasteurianum: cloning and expression of the gene encoding 1,3-propanediol dehydrogenase. FEMS Microbiol.
Lett.
154:337-345).

SUMMARY OF THE INVENTION
The present invention relates to the discovery of a mutant form of 1,3-propanediol dehydrogenase (PDD) isolated from a derivative of E.blattae capable of growth in the presence of at least 105 g/I 1,3-propanediol, levels normally toxic to wild-type E.blattae.
The present invention is therefore based in part upon the discovery that the mutant form of PDD is associated with E.blattae's resistance to normally toxic levels of 1,3-propanediol.
The present invention is also based in part upon the finding that this mutant PDD has an altered Km for 1,3-propanediol and NAD.
Accordingly, the present invention provides a mutant PDD having a Km for 1,3-propanediol that is increased over the wild-type PDD Km for 1,3-propanediol.
In one embodiment, the Km of the mutant PDD is about 3 times the Km of wild-type PDD
for 1,3-propanediol. In another embodiment, the mutant PDD has a Km of about 80 mM for 1,3-propanediol. In a further embodiment, the mutant PDD is obtainable from E.blattae ATCC
accession number PTA-92.
In yet another embodiment of the present invention, the mutant PDD comprises a mutation corresponding to residue His105 to Leu in E.blatte PDD as shown in Figure 3. In an additional embodiment, the mutant PDD comprises the amino acid shown in SEQ
ID
NO:2 and is encoded by nucleic acid having the sequence as shown in SEQ ID
NO:1.
The present invention also provides expression vectors and host cells comprising the isolated nucleic acid having the sequence as shown in SEQ ID NO:1. In one embodiment, the host cell includes Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.
In an additional aspect, the present invention relates to methods for producing 1,3-propanediol comprising the use of a microorganism comprising mutant PDD.

BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 provides the nucleic acid sequence (SEQ ID NO:1) for the mutant 1,3-propanediol dehydrogenase (PDD).
Figure 2 provides the amino acid sequence (SEQ ID NO:2) for the mutant 1,3-propanediol dehydrogenase (PDD).
Figure 3 provides an amino acid alignment of PDDs from various microorganisms.
Eb_GEBT represents the ATCC deposited E.blattae mutant PDD, Eb_429T and Eb_907T
are wild-type E.blattae (ATCC accession number 33429); Kpn is Klebsiella pneumoniae (GenBank accession # U30903); Cfu is Citrobacter freundii (GenBank accession number U09771) and Cpast is Clostridium pasteurianum (GenBank accession number AF006034).
DESCRIPTION OF THE MICROORGANISM DEPOSITS
MADE UNDER THE BUDAPEST TREATY
Applicants have made the following biological deposits under the terms of the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purposes of Patent Procedure:

Depositor Identification International Depository Date of Deposit Reference Designation Escherichia blattae PTA-92 May 19, 1999 33429 derivative Detailed Description Definitions The terms " 1,3-propanediol dehydrogenase" or "PDD" (also known in the art as "oxidoreductase") refer to the polypeptide(s) responsible for an enzyme activity that is capable of catalyzing the reduction of 3-hydroxypropionaldehyde to 1,3-propanediol.
1,3-Propanediol dehydrogenase includes, for example, the polypeptide encoded by the dhaT gene. The present invention encompasses 1,3-propanediol dehydrogenase from any source including, but not limited to E.blatte, K.pneumoniae, C.freundii, C.pasteurianum.
As used herein, the term "mutant" or "mutation" refers to any genetic change that occurs in the nucleic acid of a microorganism and may or may not reflect a phenotypic change within the microorganism. A mutation may comprise a single base pair change, deletion or insertion; a mutation may comprise a change, deletion or insertion in a large number of base pairs; a mutation may also comprise a change in a large region of DNA, such as through duplication or inversion. The amino acid sequence of a mutant 1,3-propanediol dehydrogenase can be derived from a precursor 1,3-propanediol dehydrogenase by the substitution, deletion or insertion of one or more amino acids of the naturally occurring 1,3-propanediol dehydrogenase. Methods for modifying genes (e.g., through site-directed oligonucleotide mutagenesis) have been described in the art.
The phrase "corresponding to" as used herein refers to the amino acid relatedness among 1,3-propanediol dehydrogenases as exemplified by Figure 3. Specific residues discussed herein refer to an amino acid residue number which references the number assigned to the E.blatte GEB PDD shown in Figure 3. The mutation of His to Leu is shown at residue 105 in Figure 3. Figure 3 illustrates that 1,3-propanediol dehydrogenases from a variety of microbial sources can be aligned using the algorithm CLUSTALW. The invention is not limited to the mutation of the E.blattae PDD shown in Figures 1 and 2, or the E.blattae deposited with the ATCC and having accession number PTA-92 but encompasses all PDDs containing amino acid residues at positions which are equivalent to the particular identified residue in E.blattae. A residue is equivalent if it is either homologous (i.e., corresponds in position for either the primary or tertiary structure) or analogous to a specific residue or portion of that residue in E.blattae PDD (i.e., having the same or similar functional capacity to combine, react, or interact chemically or structurally).
In order to establish homology to primary structure, the amino acid sequence of a PDD is directly compared to the E.blattae PDD primary sequence (shown in Figure 2) and particularly to a set of residues known to be invariant to all PDDs for which sequences are known (see, e.g., Figure 3). The present invention encompasses the equivalent residue change in all sources of 1,3-propanediol dehydrogenase as long as the mutant form is able to alter the Km of the activity for 1,3-propanediol. In a preferred embodiment, the Km of the mutant form is increased for 1,3-propanediol. The nucleic acid sequence of SEQ
ID NO:1 was obtained via PCR techniques. Such techniques are often characterized by inadvertent PCR generated sequence error. Therefore, the present invention also encompasses the 1,3-propanediol dehydrogenase of E.blattae having ATCC accession number PTA-92 and corresponding mutations in other microbial sources of the 1,3-propanediol dehydrogenases.
The term "Km" refers to affinity of the enzyme for the substrate. A high Km reflects a low affinity; a low Km reflects a high affinity.
The terms "carbon substrate" and "carbon source" refer to a carbon source capable of being metabolized by host organisms of the present invention and particularly carbon sources selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and one-carbon substrates or mixtures thereof.
The terms "host cell" or "host organism" refer to a microorganism capable of receiving foreign or heterologous genes and of expressing those genes to produce an active gene product.
As used herein, "nucleic acid" refers to a nucleotide or polynucleotide sequence, and fragments or portions thereof, and to DNA or RNA of genomic or synthetic origin which may be double-stranded or single-stranded, whether representing the sense or antisense strand.
The terms "native" and "wild-type" refer to a gene as found in nature with its own regulatory sequences. As used herein "amino acid" refers to peptide or protein sequences or portions thereof.
The term "expression" refers to the transcription and translation to gene product from a gene coding for the sequence of the gene product.
The terms "plasmid", "vector", and "cassette" refer to an extra chromosomal element often carrying genes which are not part of the central metabolism of the cell, and usually in the form of circular double-stranded DNA molecules. Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear or circular, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA
sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell.
"Transformation cassette" refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that facilitate transformation of a particular host cell.
"Expression cassette" refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that allow for enhanced expression of that gene in a foreign host.
The terms "isolated" or "purified" as used herein refer to a nucleic acid or amino acid that is removed from at least one component with which it is naturally associated.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to mutant 1,3-propanediol dehydrogenase (PDD) characterized by having an increased Km for 1,3 propanediol.

1. PDD Sequences Polynucleotide sequence as shown in SEQ ID NO:1 encodes the 1,3-propanediol dehydrogenase (SEQ ID NO:2) having the mutation of His to Leu at residue 105 as shown in Figure 3. As will be understood by the skilled artisan, due to the degeneracy of the genetic code, a variety of polynucleotides can encode SEQ ID NO:2. The present invention encompasses all such polynucleotides. The present invention encompasses nucleic acid encoding PDD comprising a mutation corresponding to E.blatte residue His 105 to Leu as shown in Figure 3. The nucleic acid and amino acid sequence for PDD from K.pneumoniae is given in GenBank accession number U30903; PDD from C. freundii is given in GenBank accession number U09771; for PDD from C.pasteurianum is given in GenBank accession number AF00034. The present invention also encompasses mutant PDD obtainable from E.blattae having ATCC accession number PTA-92.
Methods of obtaining desired genes from a microbial genome are common and well known in the art of molecular biology. For example, if the sequence of the gene is known, suitable genomic libraries may be created by restriction endonuclease digestion and may be screened with probes complementary to the desired gene sequence. Once the sequence is isolated, the DNA may be amplified using standard primer directed amplification methods such as polymerase chain reaction (PCR) (U.S. 4,683,202) to obtain amounts of DNA
suitable for transformation using appropriate vectors.
Alternatively, methods of using cosmid vectors for the transformation of suitable bacterial hosts are well described in Sambrook et al., Molecular Cloning: A
LaboratorY
Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbon, NY (1989).
Methods of making mutations in PDD genes are known to the skilled artisan and include for example site-directed mutagenesis, procedures described in United States patent US4760025 issued July 26, 1988.
Vectors and expression cassettes The present invention provides a variety of vectors and transformation and expression cassettes suitable for the cloning, transformation and expression of mutant PDD
as well as other proteins associated with 1,3-propanediol production into a suitable host cell.
Suitable vectors will be those which are compatible with the bacterium employed. Suitable vectors can be derived, for example, from a bacteria, a virus (such as bacteriophage T7 or a M-13 derived phage), a cosmid, a yeast or a plant. Protocols for obtaining and using such vectors are known to those in the art. (Sambrook et al., Molecular Cloning: A
Laboratory Manual - volumes 1,2,3 (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, (1989)).
Typically, the vector or cassette contains sequences directing transcription and translation of the relevant gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration. Suitable vectors comprise a region 5' of the gene which harbors transcriptional initiation controls and a region 3' of the DNA
fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell although it is to be understood that such control regions need not be derived from the genes native to the specific species chosen as a production host.
Initiation control regions or promoters, which are useful to drive expression of PDD in the desired host cell, are numerous and familiar to those skilled in the art.
Virtually any promoter capable of driving these genes is suitable for the present invention including but not limited to CYC1, HIS3, GAL1, GAL10, ADH1, PGK, PHO5, GAPDH, ADC1, TRP1, URA3, LEU2, ENO, TPI (useful for expression in Saccharomyces); AOX1 (useful for expression in Pichia); and lac, trp, IPL, IPR, T7, tac, and trc (useful for expression in E. coli).

Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary, however, it is most preferred if included.
For effective expression of the instant enzymes, DNA encoding the enzymes are linked operably through initiation codons to selected expression control regions such that expression results in the formation of the appropriate messenger RNA.

Transformation of suitable hosts and expression of PDD
Once suitable cassettes are constructed they are used to transform appropriate host cells. Introduction of the cassette containing mutant 1,3-propanediol dehydrogenase, either separately or together with other proteins necessary for the production of 1,3-propanediol, into the host cell may be accomplished by known procedures such as by transformation (e.g., using calcium-permeabilized cells, electroporation) or by transfection using a recombinant phage virus. (Sambrook et al., supra.).

Host cells Suitable host cells for the recombinant production of 1,3-propanediol may be either prokaryotic or eukaryotic and will be limited only by the host cell ability to express active enzymes. Preferred hosts will be those typically useful for production of glycerol or 1,3-propanediol such as Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas. Most preferred in the present invention are E. coli, Klebsiella species and Saccharomyces species.

Media and Carbon Substrates:
Fermentation media in the present invention must contain suitable carbon substrates. Suitable substrates may include but are not limited to monosaccharides such as glucose and fructose, oligosaccharides such as lactose or sucrose, polysaccharides such as starch or cellulose, or mixtures thereof, and unpurified mixtures from renewable feedstocks such as cheese whey permeate, cornsteep liquor, sugar beet molasses, and barley malt. Additionally, the carbon substrate may also be one-carbon substrates such as carbon dioxide, or methanol for which metabolic conversion into key biochemical intermediates has been demonstrated..
Preferred carbon substrates are monosaccharides, oligosaccharides, polysaccharides, and one-carbon substrates. More preferred are sugars such as glucose, fructose, sucrose and single carbon substrates such as methanol and carbon dioxide. Most preferred is glucose.
In addition to an appropriate carbon source, fermentation media must contain suitable minerals, salts, cofactors, buffers and other components, known to those skilled in the art, suitable for the growth of the cultures and promotion of the enzymatic pathway necessary for glycerol production. Particular attention is given to Co(I I) salts and/or vitamin B12 or precursors thereof.

Culture Conditions:
Typically, cells are grown at 30 C in appropriate media. Preferred growth media in the present invention are common commercially prepared media such as Luria Bertani (LB) broth, Sabouraud Dextrose (SD) broth or Yeast Malt Extract (YM) broth. Other defined or synthetic growth media may also be used and the appropriate medium for growth of the particular microorganism will be known by someone skilled in the art of microbiology or fermentation science. The use of agents known to modulate catabolite repression directly or indirectly, e.g., cyclic adenosine 2':3'-monophosphate or cyclic adenosine 2':5'-monophosphate, may also be incorporated into the reaction media.
Similarly, the use of agents known to modulate enzymatic activities (e.g., sulphites, bisulphites and alkalis) that lead to enhancement of glycerol production may be used in conjunction with or as an alternative to genetic manipulations.
,o Suitable pH ranges for the fermentation are between pH 5.0 to pH 9.0, where pH 6.0 to pH 8.0 is preferred as range for the initial condition.
Reactions may be performed under aerobic or anaerobic conditions where anaerobic or microaerobic conditions are preferred.
The manner and method of carrying out the present invention may be more fully understood by those of skill in the art by reference to the following examples, which examples are not intended in any manner to limit the scope of the present invention or of the claims directed thereto.

Examples Example 1 describes the kinetic changes associated with the mutant PDD shown in SEQ ID
NO:2.

Materials and Methods Strains - Wild type ATCC 33429, E.blattae comprising the mutant PDD ATCC
accession number PTA-92.

Growth - Cells were grown in a complex medium at 30C 500 ml in a 2800 ml fernbach with shaking at 225 rpm for 20 hr. The medium consists of KH2PO4, 5.4 g/L; (NH4)2SO4, 1.2 g/L; MgSO47H2O, 0.4 g/L; yeast extract, 2.0 g/L; tryptone, 2.0 g/L; and glycerol, 9.2 g/L in tap water. The pH was adjusted to 7.1 with KOH
before autoclaving (Honda, et al., 1980, J. Bacteriol, 143:1458-1465).

Extract prep - Cells were harvested by centrifugation with care to avoid anaerobic conditions. Pellets were resuspended in 100 mM Tricine pH 8.2 containing 50 mM KCI and 1 mM DTT. Cells were disrupted by passage through a French pressure cell. Crude extracts were clarified by centrifugation at 20K X g for min followed by 100K X g for 1 hr to yield the high speed supernatant (HSS) fraction.

Assays - the assay for PDD was performed as described by Johnson, E.A. et al., 1987, J. Bacteriol. 169:2050-2054.

Partial purification of PDD - HSS was separated on a 16 X 100 Poros 20HQ
column. The buffers were A, 50 mM HEPES, pH 7.4 containing 100 uM MnCl and B, A buffer containing 500 mM KCI. The column was loaded and developed at 10 mI/min. The gradient was 10 CV wash, a linear gradient to 70% B in 10 CV, and 1 CV to 100% B. The activity was detected in the very early fractions of the gradient. Pooled column fractions of the 33429 strain were used as collected for assays after the addition of additional of DTT to 1 mM. The active fractions from strain GEB031 were pooled and concentrated on a PM30 membrane and used as concentrated after the addition of additional 1 mM DTT.

Strain GD U/m PDD U/m Ratio GD/PDD
33429 0.64 0.22 2.9 GEB031 0.79 0.08 9.9 PDD Kinetics -The results are shown below.

Strain Km (mM Pro anediol Km (uM NAD

Example 2: Cloning and sequencing the 1,3-propanediol dehydrogenase genes (dhaT) from E. blattae.
The dhaT genes were amplified by PCR from genomic DNA from E. blattae as template DNA using synthetic primers (primer 1 and primer 2) based on the K.
pneumoniae dhaT sequence and incorporating an Xbal site at the 5' end and a BamHI site at the 3' end.
The product was subcloned into pCR-Blunt II-TOPO (Invitrogen). The cloning dhaT were then sequenced was standard techniques.
The results of the DNA sequencing are given in SEQ ID NO:1 and SEQ ID NO:2.
Primer 1 5'TCTGATACGGGATCCTCAGAATGCCTGGCGGAAAAT3' Primer 2 4.
5'GCGCCGTCTAGAATTATGAGCTATCGTATGTTTGATTATCTG3' As will be readily understood by the skilled artisan, nucleic acid sequence generated via PCR methods may comprise inadvertent errors. The present invention also encompasses nucleic acid encoding PDD obtainable from E.blattae having ATCC accession number PTA-92.
SEQUENCE LISTING
<110> Genencor International, Inc.

<120> Mutant 1,3-Propanediol Dehydrogenase <130> 11816-19 <140> CA 2,373,312 <141> 2000-05-16 <150> US 60/134,868 <151> 1999-05-19 <160> 4 <170> FastSEQ for Windows Version 4.0 <210> 1 <211> 1164 <212> DNA
<213> Escherichia blattae <400> 1 atgagctatc gtatgtttga ttatctggtt ccaaatgtra acttctttgg cccgggcgcc 60 gtttctgttg ttggccagcg ctgccagctg ctggggggta aaaaagccct gctggtgacc 120 gataagggcc tgcgcgccat taaagacggt gctgtcgatc agaccgtgaa gcacctgaaa 180 gccgccggta ttgaggtggt cattttcgac ggggtcgagc cgaacccgaa agacaccaac 240 gtgctcgacg gcctggccat gttccgtaaa gagcagtgcg acatgataat caccgtcggc 300 ggcggcagcc cgctcgactg cggtaaaggc attggtattg cggccaccca cccgggtgat 360 ctgtacagct atgccggtat cgaaacactc accaacccgc tgccgcccat tattgcggtc 420 aacaccaccg ccgggaccgc cagcgaagtc acccgccact gcgtgctgac taacaccaaa 480 accaaagtaa aatttgtgat tgtcagctgg cgcaacctgc cttccgtctc cattaacgat 540 ccgctgctga tgatcggcaa gcccgccggg ctgaccgccg ccaccggtat ggatgccctg 600 acccacgcgg tagaggccta tatctccaaa gacgccaacc cggttaccga tgcctctgct 660 attcaggcca tcaaactgat tgccaccaac ttgcgccagg ccgtcgccct ggggaccaac 720 ctcaaagccc gtgaaaacat ggcctgcgcc tctctgctgg ccgggatggc ctttaacaac 780 gccaacctgg gctatgttca cgccatggct caccagctgg gcggcctgta cgacatggcc 840 cacggggtgg cgaacgcggt cctgctgccc catgtctgcc gctataacct gattgccaac 900 ccggaaaaat ttgccgatat cgccaccttt atgggggaaa acaccaccgg tctttccacc 960 atggacgcag cggagctggc catcagcgcc attgcccgtc tgtctaaaga tgtcgggatc 1020 ccgcagcacc tgcgtgaact gggggtaaaa gaggccgact tcccgtacat ggcagaaatg 1080 gccctgaaag acggcaacgc cttctctaac ccgcgcaaag ggaacgaaaa agagattgcc 1140 gacattttcc gccaggcatt ctga 1164 <210> 2 <211> 387 <212> PRT
<213> Escherichia blattae <400> 2 Met Ser Tyr Arg Met Phe Asp Tyr Leu Val Pro Asn Val Asn Phe Phe Gly Pro Gly Ala Val Ser Val Val Gly Gln Arg Cys Gln Leu Leu Gly Gly Lys Lys Ala Leu Leu Val Thr Asp Lys Gly Leu Arg Ala Ile Lys Asp Gly Ala Val Asp Gln Thr Val Lys His Leu Lys Ala Ala Gly Ile Glu Val Val Ile Phe Asp Gly Val Glu Pro Asn Pro Lys Asp Thr Asn Val Leu Asp Gly Leu Ala Met Phe Arg Lys Glu Gln Cys Asp Met Ile Ile Thr Val Gly Gly Gly Ser Pro Leu Asp Cys Gly Lys Gly Ile Gly Ile Ala Ala Thr His Pro Gly Asp Leu Tyr Ser Tyr Ala Gly Ile Glu Thr Leu Thr Asn Pro Leu Pro Pro Ile Ile Ala Val Asn Thr Thr Ala Gly Thr Ala Ser Glu Val Thr Arg His Cys Val Leu Thr Asn Thr Lys Thr Lys Val Lys Phe Val Ile Val Ser Trp Arg Asn Leu Pro Ser Val Ser Ile Asn Asp Pro Leu Leu Met Ile Gly Lys Pro Ala Gly Leu Thr Ala Ala Thr Gly Met Asp Ala Leu Thr His Ala Val Glu Ala Tyr Ile Ser Lys Asp Ala Asn Pro Val Thr Asp Ala Ser Ala Ile Gln Ala Ile Lys Leu Ile Ala Thr Asn Leu Arg Gln Ala Val Ala Leu Gly Thr Asn Leu Lys Ala Arg Glu Asn Met Ala Cys Ala Ser Leu Leu Ala Gly Met Ala Phe Asn Asn Ala Asn Leu Gly Tyr Val His Ala Met Ala His Gln Leu Gly Gly Leu Tyr Asp Met Ala His Gly Val Ala Asn Ala Val Leu Leu Pro His Val Cys Arg Tyr Asn Leu Ile Ala Asn Pro Glu Lys Phe Ala Asp Ile Ala Thr Phe Met Gly Glu Asn Thr Thr Gly Leu Ser Thr Met Asp Ala Ala Glu Leu Ala Ile Ser Ala Ile Ala Arg Leu Ser Lys Asp Val Gly Ile Pro Gln His Leu Arg Glu Leu Gly Val Lys Glu Ala Asp Phe Pro Tyr Met Ala Glu Met Ala Leu Lys Asp Gly Asn Ala Phe Ser Asn Pro Arg Lys Gly Asn Glu Lys Glu Ile Ala Asp Ile Phe Arg Gln Ala Phe <210> 3 <211> 36 <212> DNA
<213> Artificial Sequence <220>
<223> primer <400> 3 tctgatacgg gatcctcaga atgcctggcg gaaaat 36 <210> 4 <211> 42 <212> DNA
<213> Artificial Sequence <220>
<223> primer <400> 4 gcgccgtcta gaattatgag ctatcgtatg tttgattatc tg 42

Claims (15)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A mutant 1,3-propanediol dehydrogenase having an increased Km for 1,3-propanediol over the corresponding wild-type 1,3-propanediol dehydrogenase Km for 1,3-propanediol, wherein the mutant 1,3-propanediol dehydrogenase comprises a mutation corresponding to residue His 105 to Leu in E. blatte, and wherein the mutant 1,3-propanediol dehydrogenase comprises the amino acid sequence shown in SEQ ID NO:2.
2. The mutant 1,3-propanediol dehydrogenase of claim 1 wherein the increased Km is about three times the wild-type Km.
3. The mutant 1,3-propanediol dehydrogenase of claim 1 having a Km of about 80mM for 1,3-propanediol.
4. The mutant 1,3-propanediol dehydrogenase of claim 1 which is obtained from E.blatte having ATCC accession number PTA-92.
5. An isolated nucleic acid encoding mutant 1,3-propanediol dehydrogenase comprising the sequence as shown in SEQ ID NO:2.
6. The isolated nucleic acid of claim 5 comprising the sequence as shown in SEQ ID NO:1.
7. An expression vector comprising the isolated nucleic acid of claim 5.
8. A host cell comprising the expression vector of claim 7.
9. The host cell of claim 8 that is selected from Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.
10. The host cell of claim 9 wherein said mutant 1,3-propanediol dehydrogenase comprises a mutation corresponding to residue His105 to Leu in E.blatte.
11. The host cell of claim 10 wherein said mutant 1,3-propanediol dehydrogenase comprises the amino acid sequence as shown in SEQ ID
NO:2.
12. A method for making 1,3-propanediol in a microorganism comprising the steps of i. obtaining a microorganism comprising a mutant 1,3-propanediol dehydrogenase (PDD) according to claim 1, said microorganism comprising at least one gene expressing a dehydratase activity, and ii. contacting said microorganism with a carbon substrate.
13. The method of claim 12 wherein said mutant 1,3-propanediol dehydrogenase is obtained from E.blatte having ATCC accession number PTA-92.
14. The method of claim 12 wherein said microorganism is selected from Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.
15. An isolated microorganism having ATCC accession number PTA-92.
CA2373312A 1999-05-19 2000-05-16 Mutant 1,3-propanediol dehydrogenase Expired - Lifetime CA2373312C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13486899P 1999-05-19 1999-05-19
US60/134,868 1999-05-19
PCT/US2000/013286 WO2000070057A2 (en) 1999-05-19 2000-05-16 Mutant 1,3-propanediol dehydrogenase

Publications (2)

Publication Number Publication Date
CA2373312A1 CA2373312A1 (en) 2000-11-23
CA2373312C true CA2373312C (en) 2010-07-20

Family

ID=22465381

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2373312A Expired - Lifetime CA2373312C (en) 1999-05-19 2000-05-16 Mutant 1,3-propanediol dehydrogenase

Country Status (12)

Country Link
US (2) US6468773B1 (en)
EP (1) EP1185667B1 (en)
JP (1) JP4646411B2 (en)
CN (1) CN1187448C (en)
AT (1) ATE485378T1 (en)
AU (1) AU777718B2 (en)
BR (1) BR0010752A (en)
CA (1) CA2373312C (en)
DE (1) DE60045125D1 (en)
IL (1) IL146172A0 (en)
MX (1) MXPA01011766A (en)
WO (1) WO2000070057A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5751000A (en) * 1999-06-18 2001-01-09 Brook Biotechnologies, Inc. Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
JP2010508013A (en) * 2006-10-31 2010-03-18 メタボリック エクスプローラー Method for biological production of 1,3-propanediol from glycerol in high yield
WO2008052596A1 (en) * 2006-10-31 2008-05-08 Metabolic Explorer Process for the biological production of n-butanol with high yield
WO2009078973A2 (en) * 2007-12-13 2009-06-25 Glycos Biotechnologies, Incorporated Microbial conversion of oils and fatty acids to high-value chemicals
WO2014009432A2 (en) * 2012-07-11 2014-01-16 Institut National Des Sciences Appliquées A microorganism modified for the production of 1,3-propanediol
WO2015051298A2 (en) 2013-10-04 2015-04-09 Genomatica, Inc. Alcohol dehydrogenase variants
CN103642765B (en) * 2013-12-25 2015-11-18 南京工业大学 Alcohol dehydrogenase mutant and application thereof
CN106609249B (en) * 2015-10-22 2019-07-23 中国科学院上海高等研究院 Klebsiella pneumoniae mutant bacteria and its application for producing 1,3- propylene glycol
CN115322261A (en) 2015-10-30 2022-11-11 基因组股份公司 Methanol dehydrogenase fusion protein
CN116622657B (en) * 2023-07-17 2023-10-24 花安堂生物科技集团有限公司 1,3-propanediol oxidoreductase mutant, fusion protein containing same and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686276A (en) * 1995-05-12 1997-11-11 E. I. Du Pont De Nemours And Company Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
DE69739715D1 (en) * 1996-11-13 2010-02-04 Du Pont PREPARATION OF 1,3-PROPANGLIUM BY RECOMBINANT ORGANISMS

Also Published As

Publication number Publication date
US20030040091A1 (en) 2003-02-27
US6468773B1 (en) 2002-10-22
DE60045125D1 (en) 2010-12-02
ATE485378T1 (en) 2010-11-15
WO2000070057A3 (en) 2001-02-08
CN1187448C (en) 2005-02-02
CA2373312A1 (en) 2000-11-23
CN1352688A (en) 2002-06-05
BR0010752A (en) 2002-02-26
AU777718B2 (en) 2004-10-28
AU5015500A (en) 2000-12-05
EP1185667B1 (en) 2010-10-20
IL146172A0 (en) 2002-07-25
MXPA01011766A (en) 2002-05-14
JP2002543843A (en) 2002-12-24
WO2000070057A2 (en) 2000-11-23
EP1185667A2 (en) 2002-03-13
US6558933B2 (en) 2003-05-06
JP4646411B2 (en) 2011-03-09

Similar Documents

Publication Publication Date Title
JP3403412B2 (en) Bioconversion of fermentable carbon source to 1,3-propanediol by a single microorganism
JP4570775B2 (en) Method for producing glycerol by recombinant organism
US7452710B2 (en) Process for the biological production of 1,3-propanediol with high titer
Arand et al. Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase
JP4592418B2 (en) Process for the biological production of 1,3-propanediol in high yield
JP2001503636A (en) Method for recombinant production of 1,3-propanediol
CN101693896B (en) Aldehyde dehydrogenase gene
EP1218530B1 (en) Novel enzymes which dehydrate glycerol
KR20150045447A (en) Recombinant microorganisms and uses therefor
CA2373312C (en) Mutant 1,3-propanediol dehydrogenase
KR20150110144A (en) Recombinant microorganism capable of producing glycerol, 3-HP, or acrylic acid and method of producing glycerol, 3-HP, or acrylic acid using the same
EP2336295B1 (en) Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium
JP2002543843A5 (en)
CN113444702B (en) Enone reductase mutant and application thereof
KR101505172B1 (en) 3-hydroxypropionic acid-producing recombinant microorganism and method of producing 3-hydroxypropionic acid using the same
EP1586647A1 (en) Process for the biological production of 1,3-propanediol with high titer
CN116064441A (en) L-pantolactone dehydrogenase mutant and encoding gene and application thereof
WO2005103262A1 (en) A novel diol dehydratase gene cluster in listeria genus

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200516